Want to see UNH full AI Analyst Report?
UNH Stock Chart & Stats
$396.59
-$3.64(-0.87%)
At close: 4:00 PM EDT
$396.59
-$3.64(-0.87%)
Day’s Range― - ―
52-Week Range$255.97 - $461.62
Previous CloseN/A
Volume851.50K
Average Volume (3M)4.21M
Market Cap
$340.27B
Enterprise Value$457.39K
Total Cash (Recent Filing)$31.47B
Total Debt (Recent Filing)$73.33B
Price to Earnings (P/E)24.4
Beta0.42
Next Earnings
Oct 21, 2026EPS Estimate
4.09Next Dividend Ex-DateN/A
Dividend Yield2.36%
Share Statistics
EPS (TTM)15.55
Shares Outstanding897,594,850
10 Day Avg. Volume4,394,320
30 Day Avg. Volume4,205,308
Financial Highlights & Ratios
PEG Ratio-1.62
Price to Book (P/B)3.19
Price to Sales (P/S)0.67
P/FCF Ratio18.69
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$481.67Price Target Upside21.45% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering21
EPS Forecast (FY)19.76
Revenue Forecast (FY)$445.72B
Bulls Say, Bears Say
Bulls Say
Durable Revenue GrowthSustained revenue expansion indicates continued demand across UnitedHealthcare and Optum rather than dependence on a single product. A growing top line can support investment in care delivery, technology, and service capabilities while improving the platform’s ability to compound over multiple quarters.
Strong Cash GenerationRobust operating and free cash flow provide meaningful financial flexibility for reinvestment, dividends, debt management, and share repurchases. Healthy free-cash-flow conversion also indicates that reported earnings are supported by cash generation, strengthening the company’s ability to fund its strategy internally.
Optum Scale And Service DepthOptum’s broad geographic reach and strong pharmacy-client retention support durable customer relationships and diversification beyond insurance underwriting. Its combination of care delivery, pharmacy services, and technology can deepen customer engagement and create multiple avenues for longer-term health-care spending growth.
Bears Say
Persistent Medical Cost PressureMedical cost growth above pricing expectations can compress insurance margins and make profitability more dependent on future pricing, reimbursement, and utilization actions. The stated delay in commercial margin recovery suggests this is a durable operating challenge that may constrain earnings quality over the next several quarters.
Medicaid Margin LossesProjected negative Medicaid margins indicate that reimbursement is not fully keeping pace with elevated medical trends. Although annualized rate actions are expected, continued losses in this business can dilute consolidated profitability and require sustained underwriting, pricing, and cost-management improvements.
Medicare Advantage Membership DeclineA substantial decline in Medicare Advantage enrollment creates a structural headwind for membership-driven premium revenue and operating scale. Even with improved Medicare margins, fewer members can reduce growth opportunities, weaken fixed-cost leverage, and increase the importance of retention and disciplined benefit pricing.
UnitedHealth News
UNH FAQ
What was UnitedHealth’s price range in the past 12 months?
UnitedHealth lowest stock price was $255.97 and its highest was $461.62 in the past 12 months.
What is UnitedHealth’s market cap?
UnitedHealth’s market cap is $340.27B.
When is UnitedHealth’s upcoming earnings report date?
UnitedHealth’s upcoming earnings report date is Oct 21, 2026 which is in 38 days.
How were UnitedHealth’s earnings last quarter?
UnitedHealth released its earnings results on Jul 16, 2026. The company reported $6.38 earnings per share for the quarter, beating the consensus estimate of $4.907 by $1.473.
Is UnitedHealth overvalued?
According to Wall Street analysts UnitedHealth’s price is currently Undervalued.
Does UnitedHealth pay dividends?
UnitedHealth pays a Quarterly dividend of $2.32 which represents an annual dividend yield of 2.36%. See more information on UnitedHealth dividends here
What is UnitedHealth’s EPS estimate?
UnitedHealth’s EPS estimate is 4.09.
How many shares outstanding does UnitedHealth have?
UnitedHealth has 897,594,850 shares outstanding.
What happened to UnitedHealth’s price movement after its last earnings report?
UnitedHealth reported an EPS of $6.38 in its last earnings report, beating expectations of $4.907. Following the earnings report the stock price went up 1.161%.
Which hedge fund is a major shareholder of UnitedHealth?
Currently, no hedge funds are holding shares in UNH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
UnitedHealth Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$481.67 (21.45% Upside)
$481.67 (21.45% Upside)
Blogger Sentiment
Bullish
UNH Sentiment 85%
Sector Average 62%
Sector Average 62%
Hedge Fund Trend
Increased
By 316.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $660.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.4%
Last 30 Days ▼ 2.0%
Last 30 Days ▼ 2.0%
News Sentiment
Very Bullish
Bullish news 82%
Bearish news 18%
Bearish news 18%
Technicals
SMA
Positive
20 days / 200 days
Momentum
10.07%
12-Months-Change
Fundamentals
Return on Equity
2.36%
Trailing 12-Months
Asset Growth
0.37%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
UnitedHealth
UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease management, and other age-specific health issues. This division further encompasses Medicaid plans, children's health insurance, dental benefits, and various hospital and clinical services. Optum Health focuses on delivering direct healthcare solutions and management services. It facilitates access to networks of specialist care providers, offers health management programs, direct care delivery, consumer engagement initiatives, and financial services. Its diverse clientele includes individuals (served directly through care systems), employers, insurance payers, and government organizations. Optum Insight specializes in providing technology, information, and consulting services to the healthcare industry. Its offerings include software and data products, advisory consulting arrangements, and outsourced managed services. Clients span hospital systems, physicians, health plans, governmental bodies, life sciences companies, and other relevant organizations. Finally, Optum Rx handles the company's pharmaceutical care services. This segment manages retail pharmacy networks, provides home prescription delivery, and offers specialty and compounding pharmacy capabilities. Leveraging its purchasing power and clinical expertise, Optum Rx also develops advanced programs related to step therapy, formulary management, medication adherence, and integrated disease and drug therapy management. UnitedHealth Group Incorporated, founded in 1977, has its corporate headquarters located in Minnetonka, Minnesota.
UNH Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call reflects a broadly positive tone: strong quarter-to-date financial results (notably double-digit EPS growth and raised guidance), solid operational progress across Optum (AI-led efficiency gains, improved care metrics), and meaningful shareholder returns and balance sheet improvement. However, the company faces notable near-term headwinds—elevated commercial medical cost trends, pressured Medicaid margins, Medicare enrollment declines, and some one-time favorable prior-period development—creating areas of ongoing focus and uncertainty. On balance, the positive developments and upgraded outlook outweigh the challenges, but management emphasizes continued urgency and investment to sustain improvement.View all UNH earnings summariesUNH Revenue Breakdown
78.70% Premiums
11.93% Products
8.50% Services
0.88% Investment and other income
UNH Stock 12 Month Forecast
Average Price Target
$481.67
▲(21.45% Upside)
Technical Analysis
Ownership Overview
0.15% Insiders
26.21% Mutual Funds
20.71% Other Institutional Investors
28.20% Public Companies and Individual Investors